Form 4: Rallybio Director Liu Hui Acquires Options in Lieu of Retainer Fees

Director Liu Hui of Rallybio Corp acquires options for common stock in lieu of retainer fees, according to a Form 4 filing.

Summary

• On January 2, 2025, Liu Hui, a director of Rallybio Corp, acquired options to purchase 67,857 shares of common stock at an exercise price of $0.95.
• The options were granted in lieu of $47,500 in retainer fees under the company's 2021 Equity Incentive Plan.
• The options vest in 12 equal monthly installments throughout 2025, and expire on January 2, 2035.
• Following the transaction, Liu Hui directly owns 67,857 derivative securities.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction (option grant in lieu of fees) and suggests continued alignment between the director and the company. It's a neutral to slightly positive indicator.

Positives

• The acquisition of options by a director demonstrates their continued investment and alignment with the company's success.
• Granting options in lieu of retainer fees conserves cash for the company.

Future Outlook

The document does not contain specific forward-looking statements, but the option grant suggests an ongoing relationship between the director and the company.

Industry Context

Option grants to directors are a common practice in the biotech industry to align management interests with shareholder value and conserve cash.

Related Party Transactions

• The option grant to Liu Hui, a director, in lieu of retainer fees is a related party transaction.

Stakeholder Impact

• Shareholders may view the option grant positively as it aligns the director's interests with the company's performance.
• The company benefits from conserving cash by issuing options instead of paying retainer fees.

Key Dates